News
The most common way to take Zofran is orally in the form of a quick-dissolving tablet. It can also be injected into your muscle or through an IV. Zofran is approved by the Food and Drug ...
Earlier on June 29, 2012, the FDA warned that Zofran 32mg single IV dose should be avoided due to the risk of a QT interval prolongation, which can lead to Torsades de Pointes, a potentially fatal ...
Brand name: Zofran ODT. Ondansetron comes in three forms that you take by mouth: a tablet, a disintegrating tablet, and a solution. It’s also available in an intravenous (IV) form. This form is ...
The dose of Zofran for hyperemesis gravidarum requiring hospitalization is a maximum of 10 milligrams via intravenous therapy (IV) every 8 hours. More typical pregnancy nausea is managed by a much ...
Ondansetron is approved for preventing chemotherapy-induced nausea and vomiting, and, in lower doses, for postoperative nausea and vomiting. The 32-mg formulation is given as a single intravenous ...
Intravenous Formulation of Esomeprazole Magnesium ... eradication to reduce the risk of duodenal ulcer recurrence. Use of Ondansetron Injection (Zofran) Allowed in Younger Infants On March ...
The FDA has issued an alert to health care professionals against the use of certain intravenous bags of metronidazole, ondansetron and ciprofloxacin because of potential contamination.
Preliminary results from a clinical study of Zofran, or ondansetron, showed a 32 mg single intravenous dose may affect the electrical activity of the heart. GlaxoSmithKline, the makers of Zofran, will ...
As per the results obtained from the clinical study conducted by the FDA, it has been found that a 32 mg dose of the drug Zofran given by intravenous route of administration may cause interference ...
Ondansetron (as HCl dihydrate) 2mg/mL; IV or IM inj. Ondansetron is a selective 5-HT3 receptor antagonist. Serotonin receptors of the 5-HT3 type are present both peripherally on vagal nerve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results